Welcome everyone, and thank you for joining us for today's presentation. My name is Torulv Gabrielsen, I am the executive chairman of Amas Water.

I'm also joined by our CFO, Mr. Morten Hilton Thomassen, who will take you through the financials and summarize the key takeaways from this presentation.

This webcast is being recorded, and a replay will be available on our website later today, together with the presentation material. Just to get the formalities out of the way, the following disclaimer applies to all content presented today.

We start with a brief overview of our recent highlights, followed by a short introduction to our company. After that, I will go through the status of our business activities and financials.

Please submit your questions by using the Q&A panel during the presentation, and we will answer as best as we can after the presentation. The growth in chemical sales we highlighted in previous quarters continue into the fourth quarter of 2025.

In fact, the last quarter marked our strongest chemical sales to date, with an increase of 44% year-over-year and a 67% increase year-to-date. Total revenues for the fourth quarter amounted to 7.2 million NOK, up from 4.7 million in the same period last year, representing a year-over-year growth of approximately 53%.

EBITDA improved by approximately 2 million NOK, representing an improvement of about 34% compared to the fourth quarter of 2024. Our technological advancements within aquaculture have resulted in two new contracts during the quarter.

One of these contracts involves equipment to be installed at a newly built factory scheduled to start production in the first half of 2026, and the second is an additional purchase order from an existing customer, a global leader in aquaculture. Regarding our activities in the Middle East oil and gas market, the pilot project for a major oil producer in Saudi Arabia, which was previously postponed due to regional geopolitical conditions, is currently scheduled for completion in the first quarter of 2026.

In Germany, the paid long-term pilot at METHA is ongoing. This represents the final qualification step toward replacing synthetic chemicals with our green alternatives at the dredging facility in Hamburg.

Upon successful completion, we proceed with commercial negotiations for a long-term contract with METHA. Finally, we completed a private placement in the beginning of the fourth quarter.

The conversion of a 12 million NOK in shareholder loan, combined with 8 million NOK in gross proceeds, demonstrates strong investor confidence in Amas Water's technology and long-term potential. Amas Water develops green technologies for water and wastewater treatment, helping industries address their water pollution challenges.

Our two main products are NovaFloc, a green and biodegradable chemical, and NovaPool, a high-performance filtration technology. In addition to these products, Amas Water delivers equipment and total solutions, combining both chemical and technical expertise to meet our clients' needs.

We have established facilities in Norway and Germany, and we also operate in the US and the Middle East through partnerships and agent agreements. More than 80% of the world's wastewater flows back into the environment without any water treatment, and about 1 to 3 million tons of nano- and microplastics are released into nature annually.

Amas Water's mission and contribution is to offer eco-friendly water treatment solutions, replacing microplastic-based chemicals and enabling the sustainable reuse of valuable sludge. The world is facing a water crisis driven by climate change, urbanization, and increasing competition for limited water sources.

In large and emerging markets such as oil and gas and dredging, urgent action is needed, both from regulatory authorities and industry players themselves. The shift towards natural products has officially begun.

According to a new published market analysis report, Amas Water is listed as one of only 10 producers of natural chemicals worldwide. We believe that Amas Water is perfectly positioned to capitalize on this huge global megatrend: scarcity of water.

We are experts in water treatment across a wide range of growing industries. We have a patented, unique, and proven technology.

We have a scalable, capital-light business model with high earnings capacity. We have already established a profitable business area within aquaculture with recurring revenue, and where we experience a growing order intake and visibility in our earnings going forward.

In addition, we are growing our tender portfolio across other business areas like dredging and oil and gas. Let's start the business update section with an overview of our growth in chemical production.

In 2025, we produced around 390,000 liters of NovaFloc, including 140,000 liters during the fourth quarter. This compares to a total production of 245,000 liters in 2024.

In terms of revenues, chemical sales increased by 67% year-over-year in 2025, with a 44% increase in the fourth quarter. Today, production for the aquaculture and oil and gas markets is handled at our Bergen facility, while chemicals for dredging applications are produced in Germany through a manufacturing partner.

Our latest technological advancements in aquaculture have resulted in two new contracts during the quarter. The first is a purchase order from our business partner, Downstream Marine, for the delivery of our sensor-based and adaptive technology to a newly built Norwegian salmon slaughterhouse.

The second is an additional purchase order from an existing customer, a global leader in the aquaculture industry. This includes a system upgrade designed to improve robustness and treatment efficiency, as well as optimize logistics related to chemical supply.

To give you some background, two years have now passed since the EU regulation were introduced in the aquaculture industry. To this date, two of Norway's 45 salmon slaughterhouses have been required to implement water treatment under the new legal framework.

Both facilities, completed in 2024, chose to integrate Amas Water's chemical NovaFloc from the very start of their operations. The third facility, mandated to implement water treatment, we also expect to supply with our eco-friendly chemicals following our recent purchase order from Downstream Marine during the quarter.

Production is estimated to start in the first half of 2026. Several slaughterhouses are still receiving feedback from the authorities regarding their exemption requests.

Far, no exemptions have been granted, but compliance deadlines ranging from two to four years have been issued. Based on current information, the majority of factories are expected to implement water treatment solutions between 2026 and 2030.

Moving forward, our goal is to capture the market as the deadlines approach. In close collaboration with our clients and Downstream Marine, we have developed and implemented solutions that help these facilities comply with the upcoming regulations, analyze data trends, and manage fluctuations in production volumes and other conditions.

We are now proud to say that our 24-hour sensor-based and adaptive chemical treatment technology has demonstrated stable operation, high purification efficiency, and strong robustness. This dedicated work has provided valuable insights that allows us to recommend treatment solutions specifically tailored to each facility.

The two contracts awarded in the fourth quarter confirm the industry's confidence in our solutions. I would also like to mention that in parallel, we are exploring sludge dewatering solutions for the industry.

Wastewater treatment and sludge management are closely linked, and Amas Water is actively researching improved dewatering methods to ensure a more complete and integrated approach in the future systems. By maintaining our leading positions, we have good visibility into future expansion as the implementation deadlines for the EU regulations approach.

Our ambitions remains high, and we are targeting a 70% market share within 2030. Over the past year, we have focused on establishing our presence in the Middle Eastern market.

Our approach has been twofold: winning contracts to pilot our technology and securing participation in tender processes for long-term deliveries of our products and solutions. Two important pilots were planned in the Middle East for 2025.

The first is an assignment to qualify our technology at an oil treatment facility in Saudi Arabia. The pilot was initially scheduled for June '25, but was postponed due to geopolitical situation in the region at the time.

The current expectation is to conduct the pilot in Q1 of 2026. Amas Water, together with our partner Envirotec Systems, has already positioned both equipment and chemicals on-site, and are prepared to initiate the project upon approval from the customer.

The second was a green deoiler technology pilot carried out in collaboration with a national oil and gas producer in Oman. The pilot has been executed and met its key technical objectives.

We are currently waiting for the customer's final evaluation report, which will determine the potential commercialization through sales of NovaFloc. Back in April 2024, we announced our first formal contract in the Middle East.

During the second half of 2025, we received the initial orders under this agreement. Project implementation is ongoing, and the first recurring commercial deliveries of NovaFloc are expected in the first half of 2026.

While currently limited in scale, the contract represents an important commercial reference and a platform for future growth in the region. In the Norwegian oil and gas market, Amas Water supplies two treatment facilities with services, technical solutions, and chemicals.

Both these facilities treat highly oil-contaminated water from oil production in the North Sea with excellent results using Amas Water's eco-friendly NovaFloc products. These installations provide stable revenues and serve as an important commercial and technical references.

For our German business, the ongoing and paid long-term pilot at METHA is currently our most important priority. METHA is a flagship in the dredging industry, recognized for its scale and leadership in sustainable dredging management, with a strong ambition to eliminate the use of synthetic chemicals in sludge dewatering.

In August, we completed the third of four qualification steps for our NovaFloc product. In October, we received a purchase order for the final step, a long-term pilot, which has now started and is expected to be finalized during the first quarter of 2026.

Far, 13,000 liters of our NovaFloc has been delivered at METHA. Upon successful completion of the final qualification step, and provided that both METHA and the Hamburg Port Authority's expectations are met, Amas Water will go into further commercial negotiations regarding long-term contracts with METHA.

I will now hand it over to Morten, who will provide you with an update on the financial and wrap up the presentation with a few key takeaways. Thank you.

Thank you, Torulv, and hello, everyone. As usual, we will start with the overview of the key figures.

Profit/loss shows improvement in all key figures compared to the previous year. In the fourth quarter, we deliver our strongest chemical sales result to date.

Total revenues in the quarter amounted to 7.2 million NOK, up from 4.7 million in Q4 2024. The revenues consist of chemical sales, equipment sales, as well as services related to process optimization and technical support.

In total, we reached a revenue of 26.5 million NOK for the year, an increase of 17% compared to 2024. The share of chemical sales relative to other sales categories increased compared to last year, and was the main driver behind the improvement in EBIT and EBITDA margins.

EBITDA showed a negative result of 3.9 million in the fourth quarter, and improvement from the negative result of 6 million in the fourth quarter of 2024. The net loss for the quarter ended at 4.9 million NOK, an improvement from 6.5 million compared to the same quarter last year.

For the year in total, net loss improved from 24.5 million in 2024 to 19 million NOK in 2025. Looking at the balance sheet, CapEx remains low, and investments in the fourth quarter totaled 0.8 million NOK, primarily directed towards patents and R&D.

Cash flow from operating activities in the quarter was negative 3.4 million NOK. The company has a credit facility of 8 million NOK in Hjelmeland Sparebank, of which 1 million was drawn as of December 31st, 2025.

In October, we completed a fully underwritten private placement, raising 8 million NOK in gross proceeds at 8 NOK per share. In addition, two existing shareholders converted shareholder loans totaling 12.6 million.

The proceeds will be used as working capital to support the company's ongoing projects and tender activities, and to meet the growing demand for NovaFloc products across all segments. Our business model is based on chemicals as a consumable for our customers, providing long-term recurring revenues.

Annual recurring revenues were 20.9 million NOK in 2025, representing a year-over-year increase of 44% for the quarter and 67% for the year. The aquaculture segment continues to deliver solid profitability, accounting for nearly 90% of total revenues during the period.

We are positive about the trend in chemical sales, as recurring revenues provide a strong foundation for future profitable growth. Now, let's take a look at the company's financial development over a longer perspective.

The company has more than doubled its revenue since 2023. As mentioned earlier, the aquaculture segment has so far been the primary growth driver.

In this market, we have high visibility regarding when slaughterhouses are required to implement water treatment solutions. This allows us to plan for a ramp-up of chemical production for future deliveries.

Our leading market position supports high growth ambitions over the next 3 to 4 years. Toward the end of this period, we expect the aquaculture segment to generate annual revenues in the range of 100 to 150 million NOK.

Dredging and oil and gas, on the other hand, are markets with significantly greater revenue potential, but involve longer lead times. Amas Water remains confident in the relevance of our solutions in these markets and the revenue potential moving forward.

Finally, here are the key takeaways from this presentation. We enter 2026 with a solid base of annual recurring revenues, with the fourth quarter delivering our strongest chemical sales to date.

The aquaculture segment continues to be our primary growth driver, delivering financial results in line with expectations. Revenues from this sector accounted for close to 90% of total revenues in 2025.

Our latest development, the sensor-based and adaptive chemical treatment technology, has resulted in two contracts during the fourth quarter, confirming the industry's confidence in our solutions. Amas Water has strong visibility into the timing of upcoming water treatment requirements in the aquaculture industry.

This provides a solid foundation for predictable market expansion and sustained growth. Activity is expected to increase gradually through 2026, followed by a period of significantly stronger growth from 2027 to 2030.

Our international growth initiatives continue to represent substantial long-term value for our company. Although markets such as dredging and oil and gas involve longer lead times and lower visibility, Amas Water remains confident in the relevance of our solutions in these markets.

Our company is fully focused on the successful execution of current and upcoming pilot projects in Germany and Saudi Arabia, with the ultimate goal of converting these into long-term contracts for our environmentally friendly technology. I will now hand it over to Fearnley for questions and answers.

Good morning, all. That concludes the presentation of results, and we will now move over to the Q&A session.

As a reminder, if you have any questions, please post them through the Q&A chat function up here on the Teams client, and we will try to cover as many as possible. Starting off, we have a few questions related to funding.

Separately from the earnings release this morning, you announced a convertible loan. Can you please provide some more color on this?

Additionally, can you please elaborate on the status of the overdraft facility?

Yes, thank you. We finalized the negotiations for this convertible loan of 10 million NOK.

It's a unsecured convertible with the price of convertible share price of 8 NOK. We believe this gives us this provides us, together with the revenue, and the projected revenue, this gives us the confidence that we can execute on the projects and our product portfolio that we have in our current state today.

It also proves that the existing shareholders are quite confident in our ability to to execute on these projects.

All right, thank you, Torulv. Secondly, we have a few questions related to the aquaculture segment.

You guide for gradual growth in 2026 and stronger growth from 2027 to 2030. Could you please be more specific on what underpins that visibility?

To follow up on that, I think you covered that quite well in the presentation, but there is an additional question related to the revenue target goal that is four times the revenue from 2025 to 2030, I believe. Can you please provide some visibility on that?

Thank you.

I think Morten covered it quite good in his presentation, but we can provide some color on it. It's basically we know all the slaughterhouses which is mandated by, and when they are kind of needs to implement this new treatment systems.

We know that the timeframe going forward for it. It's quite a good visibility, because this is a license for them to operate in this market.

We have projected that we are aiming for a 70% market share of this, based on that 19 19 of these slaughterhouses represents about 80% to 85% of the produced volume. These slaughterhouses, the majority of them, are using the disinfection systems that our partner Downstream Marine have delivered to these slaughterhouses.

We have quite good visibility and knowledge about the technical systems. We know where they are in the process, and we have a good dialogue with them.

Therefore, we have a quite good visibility for the next couple of years when it comes to the slaughterhouse market for the salmon slaughterhouses. We also know the production volume, we can calculate approximately how much chemical dosing which is needed based on their production.

We also know generally based on our historical installations, we know what kind of equipment sales each slaughterhouse represents based on their volume and capacity as well. I don't know, Morten, if you have anything more to elaborate on that?

No, I think you covered it. We have also the overview of water consumption for the industry, yeah, I think the estimations are quite good for the market potential.

Yeah. Currently it's the salmon slaughterhouses which is mandated under this law, but we also see some development in the other markets for pelagic fish.

We hope that, for us obviously, they will also be mandated under this regulation. We see a potential in other segments of the aquaculture as well in the future.

For the salmon slaughterhouses, it is quite a good visibility for us. It's therefore we can be that specific in our projected revenues going forward.

Perfect. Thank you.

The next question is also related to the aquaculture segment. Do you have any competitors in that segment?

How do you assess these alternatives if there are any? Are there any sort of new bio-based competitors emerging?

Do you see that?

I guess we have competitors. Of course, we have competitors out there, that is mainly other kind of competing technologies.

We don't see any direct competitors when it comes to what can be similar to what we are offering to them. In our experience, our solutions, our technology provides best cost-benefit for the end customer.

We also believe that it's much more about delivering and understanding how these regulations actually work than only providing a chemical or a technical solutions to it. Because these regulations and the water treatment is a quite new activity for these slaughterhouses that they need to implement.

This is a slaughterhouse and they are not usually they are not very long experience in treating water. We have accumulated a lot of knowledge about these new regulations.

I think we are in the forefront when it comes to providing not only the actual solution for it, but also how they can solve the problem, and also how they can actually make this work in the whole value chain from the treatment of the blood water to the sludge. Of course, there are competing technologies, we know that.

We believe our technology is providing the best cost-benefit. Of course, we are expecting new competitors as well, but we think we are in the forefront of this new regulations.

We have been working with it for several years now.

Perfect. Thank you.

Then a final question on the aquaculture segment. How many contracts for chemicals do you have today, and yeah, how many of them are in aquaculture?

A follow-up on that is also, how much of your revenue in the fourth quarter were generated from chemical sales versus from equipment sales in the aquaculture segment?

Morten, you can elaborate and you need to correct me on the details here. I think there was one question for chemical sales to the aquaculture, and that is three contracts.

We are delivering our NovaFloc and our chemical solutions to, as of now. I think that was a percentage of the sales to the aquaculture divided into equipment and chemicals, and I think it was around 70% in chemical sales, and the rest equipment sales.

If you look at that full-year '24 compared to '25, what is interesting about it is that the revenue composition has improved, that more of that revenue is actually recurring in revenue, as we have more chemical sales than equipment. The equipment sales that really drove the revenue in '24, that is being translated into more chemical sales in '25.

We will also see this trend going forward, that our composition of the revenue will consist more and more of the recurring chemical sales, which we also have a better margin on.

Just want to add a few things, based on the question. How many contracts with continuously supply of chemicals we have, the number is 5, and 3 of them are within aquaculture.

In addition, we also have frame agreements in Germany, where we also have minor deliveries. These contracts, of course, our aim is to also have frequent deliveries of chemicals towards these clients.

Thank you, Morten and Torulv. Moving over to dredging, on METHA, first of all, when will the fourth pilot phase be finalized, and what would be the consequences of a failed pilot?

I think it will be finalized during the first quarter, maybe going into a little bit of the second quarter, but we are aiming for finalizing it during the first quarter. If it's been extended, this is a paid pilot, we don't mind if they want to extend the pilot.

If it fails, well, the consequences pretty much lies in yeah, the outcome of it. If it fails, I guess that we will not move forward for the next commercial phase of it.

However, this pilot is ongoing. We started it before Christmas, and we know that from an operational standpoint, from a technical standpoint, we are delivering the results which are expected.

It's also depends on how you defined a fail. We know that we are delivering on the technical and operational aspects, and we know that we can have a good cost-benefit for the client.

Of course, it's a totality of the whole package and the whole system of it. I believe your question was also was it the size of the commercial contracts, Nicolai?

I don't think I've asked that, but it would be nice to know, for sure, so.

I see Petter there, yes. Just to provide you some background about METHA, this is the largest dredging facility, and they currently have two chamber filter press and six belt filter press at this plant.

We are now doing this for the chamber filter press. A reasonable assumption would be that if we are succeeding in all the criterias and moving into the commercial phase, we will implement this first on the chamber filter press, and then move over to the belt filter press.

They will also change the belt filters and install new chamber filter press for it. In total, we believe conservatively that it could represent maybe 1.5 million to 1.6 million euros in annual recurring revenue.

That is a conservative estimate. Around plus 15 million to 20 million, depending on the exchange rates, in recurring revenue for this plant implemented on all the production lines.

Okay. Just to follow up on that, Torulv.

If I remember correctly, your trial is based on 1/3 of the production capacity at METHA, right? If your trial succeeds and you go to commercialization, do you believe you will sell chemicals for 1/3 of the production facility or the whole thing?

Like I said, we are currently on the chamber filter press, which, as you say, represents about 1/3, maybe a little bit more. I believe that our solution will be implemented in stages.

That's correct. I don't think that we will come into full-scale deliveries for the whole plant for the first stage, because we also need to test it on the belt filter press.

What we're aiming for is actually to accelerate that process, we can also test it in parallel on the belt filter. Currently, which is now being tested on the chamber filter press.

Regarding what you said about the capacity, what we are seeing is actually that the capacity, even though the chamber filter press, they only have two two of them, we see that the use of our products actually means some less downtime for these production lines, because the sheer stability of the sludge. The amount that these two lines represents can actually be increased compared to the total volume.

The timeline, well, the timeline, this pilot is ongoing. It will probably be finished, as I said, during the first quarter, maybe extended.

For us, if it's extended, that is probably because we can extend it to test on the belt filter press, and it's also paid, so that's a good thing. The next phase would be commercial negotiations for a long-term delivery contract.

How long that's going to take, that's kind of hard for me to have an estimate on, but of course we are wanting to close this as soon as possible. We also think that if it ticks all the boxes, the commercial and the technical aspects and operations, it's quite a big incentive for the facility to implement this as well, because of the cost-benefit by using our products, and also the indirect cost-benefit that our products do have a lower carbon footprint, which represents also an indirect and in certain cases a direct cost for the client with a higher carbon footprint.

Hopefully, negotiations can be concluded during the second quarter, maybe moving into the third quarter. As we are negotiating with them, we will hopefully also be delivering chemicals to them in parallel, we can have a continuous revenue stream from this operation.

Perfect. Thank you.

I think we can wrap up the METHA chapter for now. I also have a question on the Vibro- contract that you have, because that also represents quite significant revenue potential.

Can you please just update us on the status of that frame contract?

Yes. I think we communicated in earlier reporting that we have executed quite a few of these pilots with Vibro.

The pilots showed that there are some minor modifications needed to be done on the equipment side that our partner Vibro is delivering. They are in the process of doing this equipment modifications at their own cost, because they see the potential by using our products.

We are scoping or finding a larger ponds or a larger projects that we can implement this to for the next pilots. I believe that it's an ongoing work, but I believe that large-scale next pilot will be conducted maybe in the end of the first quarter or maybe in the second quarter for this.

Thanks. If I remember correctly, Vibro has 20 mobile dredging units?

How

Yeah. No.

No, I think it's more 10 10-11. 10-11,

yes. Thank you.

Sorry. How many units do you sort of project that you'll be selling chemicals to?

We hope of course for all of them, but we need to also see the specific sites. As I said, we need to fine-tune the equipment a little bit.

The best cost-benefit would be to look at larger sites where this is applicable. We don't see any changes in what we have communicated before, but we see that we need to optimize the equipment for our solutions for it.

They're currently in the process of doing it, because they see that it's really a big push from the market to transfer over to biodegradable products right now. We are moving as fast as we can on the Vibro contract, but at the same time we need to be honest that the METHA contract has taken a lot of our resources as well to it.

I see. Thank you.

Are you able to sort of quantify a probability of turning the oil and gas trials into full-scale contracts?

That is quite hard. I really don't want to do that, because it's a lot of parameters to it.

I can try to give some color on it. Let's take the pilot that was being postponed and we are aiming to execute this and start this in the first quarter of 2026.

What I can say, which we have also written, is that we have the equipment on-site, we have personnel on-site, and we have the chemicals on-site, and we are just waiting for the time window. This is one of the largest facilities in the Middle East, obviously it needs a lot of planning, but we are on-site and we hope to execute as soon as possible.

If it meets all the technical and operational parameters, of course, it's also a commercial aspect of it, and turning it into a full-scale pilot, I think that is a quite good likelihood if we succeed on the technical and operational boxes. A full-scale pilot, that is I will not say a percentage, but it's very likely that will be turned into a full-scale pilot if we succeed on the first stage.

That's good to hear. I think we reached the end of the questions.

I would like to thank you all for contributing. Thank you, Morten and Torulv, for letting us host your quarterly presentation.

With that, I'll just leave the word over to you, Morten and Torulv, for some concluding remarks. Thanks.

Thank you, everyone. Yes, if you have any questions or want to visit the facility, just let us know, and you are welcome anytime.

Thanks for your support. Thank you, Nicolai.